Sigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer

por Zeng, C, Vangveravong, S, McDunn, J E, Hawkins, W G, Mach, R H
Publicado 2013

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients

por Szkandera, J, Gerger, A, Liegl-Atzwanger, B, Absenger, G, Stotz, M, Samonigg, H, Maurer-Ertl, W, Stojakovic, T, Ploner, F, Leithner, A, Pichler, M
Publicado 2013

Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

por Bartlett, J M S, Brookes, C L, Piper, T, van de Velde, C J H, Stocken, D, Lyttle, N, Hasenburg, A, Quintayo, M A, Kieback, D G, Putter, H, Markopoulos, C, Kranenbarg, E M-K, Mallon, E A, Dirix, L Y, Seynaeve, C, Rea, D W
Publicado 2013

MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis

por Silva-Santos, R M, Costa-Pinheiro, P, Luis, A, Antunes, L, Lobo, F, Oliveira, J, Henrique, R, Jerónimo, C
Publicado 2013

Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin–integrin signalling in head and neck squamous cell carcinoma

por Kinoshita, T, Nohata, N, Hanazawa, T, Kikkawa, N, Yamamoto, N, Yoshino, H, Itesako, T, Enokida, H, Nakagawa, M, Okamoto, Y, Seki, N
Publicado 2013

First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate can...

por Bianchini, D, Omlin, A, Pezaro, C, Lorente, D, Ferraldeschi, R, Mukherji, D, Crespo, M, Figueiredo, I, Miranda, S, Riisnaes, R, Zivi, A, Buchbinder, A, Rathkopf, D E, Attard, G, Scher, H I, de Bono, J, Danila, D C
Publicado 2013

Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment

por Thiel, U, Koscielniak, E, Blaeschke, F, Grunewald, T G P, Badoglio, M, Diaz, M A, Paillard, C, Prete, A, Ussowicz, M, Lang, P, Fagioli, F, Lutz, P, Ehninger, G, Schneider, P, Santucci, A, Bader, P, Gruhn, B, Faraci, M, Antunovic, P, Styczynski, J, Krüger, W H, Castagna, L, Rohrlich, P, Ouachée-Chardin, M, Salmon, A, Peters, C, Bregni, M, Burdach, S
Publicado 2013

Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma

por Aryee, D N T, Niedan, S, Ban, J, Schwentner, R, Muehlbacher, K, Kauer, M, Kofler, R, Kovar, H
Publicado 2013

The effect of metformin on apoptosis in a breast cancer presurgical trial

por Cazzaniga, M, DeCensi, A, Pruneri, G, Puntoni, M, Bottiglieri, L, Varricchio, C, Guerrieri-Gonzaga, A, Gentilini, O D, Pagani, G, Dell'Orto, P, Lazzeroni, M, Serrano, D, Viale, G, Bonanni, B
Publicado 2013

An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes

por Pinato, D J, Tan, T M, Toussi, S T K, Ramachandran, R, Martin, N, Meeran, K, Ngo, N, Dina, R, Sharma, R
Publicado 2014

Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors

por Zeng, L, Tian, Y-M, Sun, X-M, Chen, C-Y, Han, F, Xiao, W-W, Deng, X-W, Lu, T-X
Publicado 2014

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients

por Zeestraten, E C M, Reimers, M S, Saadatmand, S, Dekker, J-W T, Liefers, G J, van den Elsen, P J, van de Velde, C J H, Kuppen, P J K
Publicado 2014

Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry

por Woehrer, A, Hackl, M, Waldhör, T, Weis, S, Pichler, J, Olschowski, A, Buchroithner, J, Maier, H, Stockhammer, G, Thomé, C, Haybaeck, J, Payer, F, von Campe, G, Kiefer, A, Würtz, F, Vince, G H, Sedivy, R, Oberndorfer, S, Marhold, F, Bordihn, K, Stiglbauer, W, Gruber-Mösenbacher, U, Bauer, R, Feichtinger, J, Reiner-Concin, A, Grisold, W, Marosi, C, Preusser, M, Dieckmann, K, Slavc, I, Gatterbauer, B, Widhalm, G, Haberler, C, Hainfellner, J A
Publicado 2014

Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer

por Granata, A, Nicoletti, R, Tinaglia, V, De Cecco, L, Pisanu, M E, Ricci, A, Podo, F, Canevari, S, Iorio, E, Bagnoli, M, Mezzanzanica, D
Publicado 2014

Association of sedentary behaviour with colon and rectal cancer: a meta-analysis of observational studies

por Cong, Y J, Gan, Y, Sun, H L, Deng, J, Cao, S Y, Xu, X, Lu, Z X
Publicado 2014

A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell l...

por Chen, H, Modiano, M R, Neal, J W, Brahmer, J R, Rigas, J R, Jotte, R M, Leighl, N B, Riess, J W, Kuo, C J, Liu, L, Gao, B, DiCioccio, A T, Adjei, A A, Wakelee, H A
Publicado 2014

Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer

por Jonker, D J, Karapetis, C S, Harbison, C, O'Callaghan, C J, Tu, D, Simes, R J, Malone, D P, Langer, C, Tebbutt, N, Price, T J, Shapiro, J, Siu, L L, Wong, R P W, Bjarnason, G, Moore, M J, Zalcberg, J R, Khambata-Ford, S
Publicado 2014

Using multiple cytokines to predict hepatocellular carcinoma recurrence in two patient cohorts

por Chen, Z-Y, Wei, W, Guo, Z-X, Peng, L-X, Shi, M, Li, S-H, Xiao, C-Z, Zhong, C, Qian, C-N, Guo, R-P
Publicado 2014

Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma

por Bharwani, N, Miquel, M E, Powles, T, Dilks, P, Shawyer, A, Sahdev, A, Wilson, P D, Chowdhury, S, Berney, D M, Rockall, A G
Publicado 2014

Pazopanib exposure decreases as a result of an ifosfamide-dependent drug–drug interaction: results of a phase I study

por Hamberg, P, Boers-Sonderen, M J, van der Graaf, W T A, de Bruijn, P, Suttle, A B, Eskens, F A L M, Verweij, J, van Herpen, C M L, Sleijfer, S
Publicado 2014